|
|
 |
|
Viewing report
|
|
|
|
Gastroesophageal Reflux Disease - Drug Pipeline Analysis and Market Forecasts to 2016
GlobalData , April 2010, Pages: 42
Gastroesophageal Reflux Disease - Drug Pipeline Analysis and Market Forecasts to 2016
Summary
“Gastroesophageal Reflux Disease (GERD) - Drug Pipeline Analysis and Market Forecasts to 2016” is an essential source of information and analysis on the global gastroesophageal reflux disease market. The report identifies the key trends shaping and driving the global gastroesophageal reflux disease market. The report also provides insight on the prevalent competitive landscape and the emerging players expected to bring significant shift in the market positioning of the existing market leaders. Most importantly, the report provides valuable insight on the pipeline products within the global gastroesophageal reflux disease sector.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in house analysis by Our team of industry experts.
Scope
The report provides information on the key driver and challenges of the global GERD market. Its scope includes:
- Annualized global GERD market revenues data from 2000 to 2009, forecast forward for 7 years to 2016.
- Key geographies covered in this report include the US, the UK, Italy, Spain, Germany, France, and Japan.
- Pipeline analysis data providing a split across different phases, mechanism of action being developed and emerging trends. Key classes of mechanism of action include H+/K+ ATPase Inhibitor, H2 antagonist, 5-HT4 receptor agonist, GABA-B receptor Agonist and mGluR5 antagonist.
- Analysis of the current and future market competition in the global GERD market. Key market players covered are AstraZeneca, Addex Pharmaceuticals, XenoPort and Vecta.
- Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide qualitative analysis of its implications.
- Key topics covered include strategic competitor assessment, market characterization, unmet needs and implications for future market associated with GERD.
Reasons to buy
The report will enhance your decision making capability in a more rapid and time sensitive manner. It will allow you to:
- Develop and design your in-licensing and out-licensing strategies through review of pipeline products and technologies and by identifying companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving the global gastro-oesophageal reflux disease market.
- Drive revenues by understanding key trends, innovative products and technologies, market segments and companies likely to impact the global gastro-oesophageal reflux disease market in future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
- What’s the next big thing in the global gastro-oesophageal reflux disease market landscape? - Identify, understand and capitalize.
Customers who bought this item also bought
Gastroesophageal Reflux Disease (GERD) Therapeutics - Pipeline Assessment and Market Forecasts to 2017
Gastroesophageal Reflux Disease (GERD) Therapeutics - Pipeline Assessment and Market Forecasts to 2018
Gastroesophageal Reflux Disease - Pipeline Review, Q1 2011
Gastroesophageal Reflux Disease - Pipeline Review, Q4 2010
Gastrointestinal Disorder Therapeutics Market to 2017 - Crohn's Disease and Irritable Bowel Syndrome Markets Show Strongest Growth
Reflux Esophagitis (Gastroesophageal Reflux Disease) - Pipeline Review, H2 2011
Gastroesophageal Reflux Disease Global Clinical Trials Review, Q1, 2011
Digestive System Gastroesophageal Reflux Disease
Esophagitis - Pipeline Review, H2 2011
Drug Discovery and Preclinical Molecules by Therapy Area - Innovation Focuses on Stem Cell Therapies and Gene Therapies
|
|
|
|
